Stay updated on Resmetirom in NASH and Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Resmetirom in NASH and Fibrosis Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Expanded recruitment locations to include numerous sites across the United States and internationally, and added related topics such as Non-alcoholic fatty liver disease and MedlinePlus Genetics. The HHS Vulnerability Disclosure item was removed.
    Difference
    2%
    Check dated 2025-12-20T23:59:24.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Deleted related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-13T19:29:12.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    - Added related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics.
    Difference
    0.0%
    Check dated 2025-12-06T14:51:26.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2 under additions. Removed 'Non-alcoholic fatty liver disease', 'MedlinePlus Genetics' related topic, and Revision: v3.3.1 from deletions.
    Difference
    0.1%
    Check dated 2025-11-29T03:01:27.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Added 'Non-alcoholic fatty liver disease' and related topics (MedlinePlus Genetics) to the study page, and kept the note that publications are automatically pulled from PubMed. The older PubMed-related note was removed and the revision tag updated from v3.2.0 to v3.3.1.
    Difference
    0.6%
    Check dated 2025-11-22T00:36:16.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Summary
    The government funding status notice and related topics (Non-alcoholic fatty liver disease and MedlinePlus Genetics) were removed from the page; core study details and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-14T18:38:52.000Z thumbnail image

Stay in the know with updates to Resmetirom in NASH and Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.